Efficacy of an Internal Teat Sealant, Orbeseal, for Reduction of Clinical Mastitis during the First 60 Days Post-partum

Authors

  • C. Sanford Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown PEI, CANADA
  • G. Keefe Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown PEI, CANADA
  • I. Dohoo Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown PEI, CANADA
  • K. Leslie Dept. of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph Ontario, CANADA

DOI:

https://doi.org/10.21423/aabppro20044943

Keywords:

Clinical mastitis, post-partum period, intramammary infections, keratin seal, OrbeSeal, teat sealant

Abstract

Clinical mastitis (CM) events often occur during the post-partum period and are important economically. Many CM cases result from infections that have been established during the dry period. In one study, 38.1% of clinical cases had the same bacteria isolated at some point during the dry period.4 Risk factors for development of new intramammary infections (IMI) in the dry period have been reviewed.2 Among the risk factors identified was failure to develop a natural keratin seal in 23.4% of teats.2 These open quarters were 1.8 times more likely to develop a new intramammary infection (IMI). Efficacy of the internal teat sealant, OrbeSeal* (OS) for prevention of new IMis during the dry period has been well established.1,3,5-7 The objective of this study was to evaluate the efficacy of OS infused at dry-off for the reduction of new cases of CM during the first 60 days of lactation, as compared to routine intramammary dry cow antibiotic therapy (DCT).

Cover image of the 37th Conference Proceedings: Cattle in pens that stretch to the horizon. Yellow background.

Downloads

Published

2004-09-23

Issue

2004

Section

Research Summaries - Dairy I

Most read articles by the same author(s)

1 2 3 4 > >>